QT
KYTX icon

Quantbot Technologies’s Kyverna Therapeutics KYTX Stock Holding History

Quantbot Technologies’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$190K Buy
21,287
+20,465
+2,490% +$182K 0.01% 1290
2026
Q1 		$7.09K Buy
+822
New +$6.85K ﹤0.01% 1561

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Quantbot Technologies's KYTX Position: Q2 2026 in Review

Quantbot Technologies increased its Kyverna Therapeutics (KYTX) stake by 2,490% in Q2 2026, buying an estimated $182K and bringing the position to 21,287 shares worth $190K. The position accounts for 0.01% of the portfolio, ranked #1290.

Quantbot Technologies first reported a position in KYTX in Q1 2026 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Quantbot Technologies held 21,287 shares of Kyverna Therapeutics worth $190K as of Q2 2026.
  • Quantbot Technologies bought 20,465 Kyverna Therapeutics shares in Q2 2026, an estimated $182K.
  • Kyverna Therapeutics made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1290 holding.
  • Quantbot Technologies first reported a position in Kyverna Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 121 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.